Target-focused pharmacophore modeling

webinar

Tue, 24 Apr 2018, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Charité

Target-focused pharmacophore modeling

Various computational tools and molecular modeling platforms are known to support medicinal chemists in understanding bioactivities, predicting binding events and rationally designing drug molecules. Among them, the pharmacophore approach is an accurate and minimal 3D-abstraction of chemical structures and intermolecular interactions.

Pharmacophore models are usually derived from a group of molecules in absence of structural information on their biological targets (ligand-based approach) or from a ligand-target complex (structure-based approach). However, only a limited amount of solutions exists to model comprehensive pharmacophores using the information of a particular target structure without knowledge of any binding ligand. In the presented work, T2F-Pharm, a fully automated tool for Truly Target-Focused Pharmacophore modeling will be introduced. Using a grid-based approach, this method samples the protein cavity, filters the grid points by energy level and clusters them into low energy hot spots. Subsequently, key features in the pocket required for optimal interaction in a 3D-pharmacophore model are derived.

T2F-Pharm represents a valuable instrument for drug discovery to investigate protein surfaces in absence of known binding partners, e.g. in cases of rather unexplored binding sites including allosteric pockets.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on